Health Canada and the Canadian Vaping Association meeting: Regulation of Vaping Products – August 11, 2020

Download the alternative format
(PDF format, 675 KB, 6 pages)

Subject:

Quarterly Update Call

Date:

August 11, 2020

Participants:

Health Canada (HC)

Canadian Vaping Association (CVA)

Introduction:

A meeting was held at the request of the CVA to present:

The Chair opened the meeting by doing round table introductions. The Chair reminded participants that this meeting is subject to disclosure as per HC's Openness and Transparency policies. In the interest of transparency, the department stated that it would be making a record of the meeting publicly available. The handling of information and privacy notice was mentioned and acknowledged.

Subjects:

Science and Hammond study update
The CVA indicated they were surprised by the changes found in the Hammond report released in spring 2020. However, they indicated that the report maintained that there was no correlation between vaping leading to an uptake in smoking.

The CVA asked if HC had a chance to review the updated report. HC indicated that they were aware of the change in data.

British Columbia and Ontario vape regulations update
The CVA has provided provincial governments with guidance that interprets the federal vaping legislation.

In discussions with British Columbia (BC) on their proposed new vaping regulations, the CVA proposed that BC adopt the Vaping Products Labelling and Packaging Regulation definition for the term "plain packaging".

The CVA is concerned that potential regulations around flavoured vaping products and nicotine concentration caps will have a negative effect on the vaping industry. The CVA indicated that they have observed vape shop closures in provinces where bans on flavours and nicotine concentration levels have been implemented.

HC asked if the CVA had observed any industry reactions to the new Vaping Products Promotion Regulations (VPPR). The CVA supports the new regulations. The CVA has been providing guidance to industry; however, there are questions and concerns from industry around age gating on social media and health warnings.

Questions in regards to Gazette II
The CVA indicated that there has been progress on child resistant containers but it has not been without challenges. There have been delays in developing compliant vaping products due to impacts of the COVID-19 pandemic. HC indicated that they are aware of the impacts of the pandemic and suggested that the CVA formally submit their concerns in writing to HC for further consideration.

The CVA asked HC if any consideration had been given to existing non-child resistant container vaping products and whether industry can continue to sell replacement parts for these devices post implementation of the Vaping Products Labelling and Packaging Regulations. HC suggested that the CVA submit details regarding replacement parts to HC for consideration and to determine where replacement parts fit within the regulations.

Nicotine concentration
The CVA sought clarification about potential regulatory proposals to restrict nicotine concentration and flavours in vaping products. HC indicated that a cost questionnaire was distributed to the vaping industry to better understand the expected financial impacts of a regulation related to nicotine concentration. Should regulatory proposals be developed, they will follow the regulatory process and be published in the Canada Gazette.

The CVA raised significant concerns with a restriction to flavours and indicated they would provide studies to HC.

Emissions and toxicology & update on good manufacturing practices (GMP) standards
The CVA inquired about the request for proposal - Tobacco and Vaping Product Analysis, specifically if the results will be publically available and if industry should expect upcoming regulations.

HC indicated that an updated guidance document clarifying requirements under the Canadian Consumer Product Safety Act touches upon toxicology and GMP standards. The uptake of this guidance document will help determine the regulatory path forward.

The CVA held a GMP summit in the United States and provided a report to HC. The CVA would like to see GMP standards / ISO certification for manufacturers of vaping products.

HC asked if the CVA was aware of any other governmental authorities considering GMP standards for vaping products. The CVA indicated that they are not aware of any regulations in other countries at the federal level.

Age gating and verification
The CVA indicated that it is providing as much guidance as possible around age gating. The CVA noted that point of entry age gating is difficult; however, point of sale is a much more viable solution. The CVA asked if there was any guidance for industry.

HC indicated that a VPPR fact sheet was sent to stakeholders which, provides examples of non-compliance.

Foreign market imports
The CVA is concerned by the number of non-compliant vaping products entering the Canadian market from foreign websites that are not age gated. There is also a rise in social sales - social media platforms selling vaping products. These platforms do not verify the age of purchasers. The CVA noted that HC could look at compliance promotion to address this issue.

Conclusion:

The meeting was then concluded.

Documents:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: